ArticleJournal for immunotherapy of cancer2025

Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma.

Shuang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.